Nephros INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
Nephros, Inc. announced a significant increase in net income and revenue for fiscal year 2025, driven by higher programmatic sales and emergency response business, despite ongoing tariff impacts and an identified material weakness in internal controls.
NASDAQ
Nephros, Inc. achieves its first profitable year with a net income of $0.1 million, despite a slight revenue decrease due to reduced emergency response orders.
NASDAQ
Nephros, Inc. and Medica S.p.A. have entered into a new license and supply agreement, extending their collaboration for the marketing and supply of filtration products through December 31, 2028.